In a hyperaldosteronism test, Calvier et al. (2015) found that increased expression of Gal-3 is associated with cardiac and renal fibrosis, which is alleviated by drug inhibition, inhibition of Gal effects, or Gal-3 gene alterations. This evidence concerns the gene GAL and renal fibrosis.